| New Beginnings Counseling Center, Llc | |
|
5930 Seminole Centre Ct Ste C Fitchburg WI 53711-5165 | |
| (608) 630-8889 | |
| (608) 200-7268 |
| Full Name | New Beginnings Counseling Center, Llc |
|---|---|
| Speciality | Clinic/Center |
| Location | 5930 Seminole Centre Ct Ste C, Fitchburg, Wisconsin |
| Authorized Official Name and Position | Frederick Andre Harris (OWNER/PSYCHOTHERAPIST) |
| Authorized Official Contact | 6086308889 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| New Beginnings Counseling Center, Llc 5930 Seminole Centre Ct Ste C Fitchburg WI 53711-5165 Ph: (608) 630-8889 | New Beginnings Counseling Center, Llc 5930 Seminole Centre Ct Ste C Fitchburg WI 53711-5165 Ph: (608) 630-8889 |
| NPI Number | 1386250561 |
|---|---|
| Provider Enumeration Date | 09/22/2020 |
| Last Update Date | 07/31/2023 |
| Certification Date | 07/31/2023 |
| Medicare PECOS PAC ID | 8325446420 |
|---|---|
| Medicare Enrollment ID | O20211004002015 |
News Archive
A new study has found children are far more at risk of injury in the bath or shower from slips, trips and falls, than from scalding or drowning and most injuries occur to children under age 4.
ViroPharma Incorporated today announced that data from Phase 3 studies of Cinryze (C1 esterase inhibitor [human]) have been published in the August 5, 2010 issue of the New England Journal of Medicine. The paper entitled Nanofiltered C1 Inhibitor Concentrate for Treatment of Hereditary Angioedema by Dr. Bruce L. Zuraw et al. describes the safety and efficacy of Cinryze in treating and preventing attacks of hereditary angioedema. Cinryze is the first and only FDA-approved C1 esterase inhibitor therapy indicated for routine prophylaxis against angioedema attacks in adolescent and adult patients with hereditary angioedema (HAE), a rare, debilitating and potentially fatal disease; it is not approved by the FDA to treat acute angioedema attacks.
New research finds a strong link between healthcare-associated infections (HAIs) and patient readmission after an initial hospital stay. The findings, published in the June 2012 issue of Infection Control and Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America (SHEA), suggest that reducing such infections could help reduce readmissions, considered to be a major driver of unnecessary healthcare spending and increased patient morbidity and mortality.
Of all the indignities that come with aging, excessive earwax may be the most insidious.
› Verified 2 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386250561 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QM0801X | Clinic/center - Mental Health (including Community Mental Health Center) | (* (Not Available)) | Primary |
| Provider Name | Lucas E Moore |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1477837607 PECOS PAC ID: 9436432606 Enrollment ID: I20170214000355 |
News Archive
A new study has found children are far more at risk of injury in the bath or shower from slips, trips and falls, than from scalding or drowning and most injuries occur to children under age 4.
ViroPharma Incorporated today announced that data from Phase 3 studies of Cinryze (C1 esterase inhibitor [human]) have been published in the August 5, 2010 issue of the New England Journal of Medicine. The paper entitled Nanofiltered C1 Inhibitor Concentrate for Treatment of Hereditary Angioedema by Dr. Bruce L. Zuraw et al. describes the safety and efficacy of Cinryze in treating and preventing attacks of hereditary angioedema. Cinryze is the first and only FDA-approved C1 esterase inhibitor therapy indicated for routine prophylaxis against angioedema attacks in adolescent and adult patients with hereditary angioedema (HAE), a rare, debilitating and potentially fatal disease; it is not approved by the FDA to treat acute angioedema attacks.
New research finds a strong link between healthcare-associated infections (HAIs) and patient readmission after an initial hospital stay. The findings, published in the June 2012 issue of Infection Control and Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America (SHEA), suggest that reducing such infections could help reduce readmissions, considered to be a major driver of unnecessary healthcare spending and increased patient morbidity and mortality.
Of all the indignities that come with aging, excessive earwax may be the most insidious.
› Verified 2 days ago
| Provider Name | Christine M Taylor |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1679965024 PECOS PAC ID: 6103224209 Enrollment ID: I20211004002207 |
News Archive
A new study has found children are far more at risk of injury in the bath or shower from slips, trips and falls, than from scalding or drowning and most injuries occur to children under age 4.
ViroPharma Incorporated today announced that data from Phase 3 studies of Cinryze (C1 esterase inhibitor [human]) have been published in the August 5, 2010 issue of the New England Journal of Medicine. The paper entitled Nanofiltered C1 Inhibitor Concentrate for Treatment of Hereditary Angioedema by Dr. Bruce L. Zuraw et al. describes the safety and efficacy of Cinryze in treating and preventing attacks of hereditary angioedema. Cinryze is the first and only FDA-approved C1 esterase inhibitor therapy indicated for routine prophylaxis against angioedema attacks in adolescent and adult patients with hereditary angioedema (HAE), a rare, debilitating and potentially fatal disease; it is not approved by the FDA to treat acute angioedema attacks.
New research finds a strong link between healthcare-associated infections (HAIs) and patient readmission after an initial hospital stay. The findings, published in the June 2012 issue of Infection Control and Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America (SHEA), suggest that reducing such infections could help reduce readmissions, considered to be a major driver of unnecessary healthcare spending and increased patient morbidity and mortality.
Of all the indignities that come with aging, excessive earwax may be the most insidious.
› Verified 2 days ago
| Provider Name | Anthony James Utrie |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1811562739 PECOS PAC ID: 0042677130 Enrollment ID: I20230605003319 |
News Archive
A new study has found children are far more at risk of injury in the bath or shower from slips, trips and falls, than from scalding or drowning and most injuries occur to children under age 4.
ViroPharma Incorporated today announced that data from Phase 3 studies of Cinryze (C1 esterase inhibitor [human]) have been published in the August 5, 2010 issue of the New England Journal of Medicine. The paper entitled Nanofiltered C1 Inhibitor Concentrate for Treatment of Hereditary Angioedema by Dr. Bruce L. Zuraw et al. describes the safety and efficacy of Cinryze in treating and preventing attacks of hereditary angioedema. Cinryze is the first and only FDA-approved C1 esterase inhibitor therapy indicated for routine prophylaxis against angioedema attacks in adolescent and adult patients with hereditary angioedema (HAE), a rare, debilitating and potentially fatal disease; it is not approved by the FDA to treat acute angioedema attacks.
New research finds a strong link between healthcare-associated infections (HAIs) and patient readmission after an initial hospital stay. The findings, published in the June 2012 issue of Infection Control and Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America (SHEA), suggest that reducing such infections could help reduce readmissions, considered to be a major driver of unnecessary healthcare spending and increased patient morbidity and mortality.
Of all the indignities that come with aging, excessive earwax may be the most insidious.
› Verified 2 days ago
News Archive
A new study has found children are far more at risk of injury in the bath or shower from slips, trips and falls, than from scalding or drowning and most injuries occur to children under age 4.
ViroPharma Incorporated today announced that data from Phase 3 studies of Cinryze (C1 esterase inhibitor [human]) have been published in the August 5, 2010 issue of the New England Journal of Medicine. The paper entitled Nanofiltered C1 Inhibitor Concentrate for Treatment of Hereditary Angioedema by Dr. Bruce L. Zuraw et al. describes the safety and efficacy of Cinryze in treating and preventing attacks of hereditary angioedema. Cinryze is the first and only FDA-approved C1 esterase inhibitor therapy indicated for routine prophylaxis against angioedema attacks in adolescent and adult patients with hereditary angioedema (HAE), a rare, debilitating and potentially fatal disease; it is not approved by the FDA to treat acute angioedema attacks.
New research finds a strong link between healthcare-associated infections (HAIs) and patient readmission after an initial hospital stay. The findings, published in the June 2012 issue of Infection Control and Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America (SHEA), suggest that reducing such infections could help reduce readmissions, considered to be a major driver of unnecessary healthcare spending and increased patient morbidity and mortality.
Of all the indignities that come with aging, excessive earwax may be the most insidious.
› Verified 2 days ago
The Emdr Center For Relationships & Healing, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2916 Marketplace Drive, Suite # 212, Fitchburg, WI 53719 Phone: 608-325-9500 Fax: 888-345-6310 | |
Mental Health Collective, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2961 Yarmouth Greenway Dr Ste B, Fitchburg, WI 53711 Phone: 608-445-6064 Fax: 608-416-1535 | |
Affirmed Family Psychotherapy Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 2961 Yarmouth Greenway Dr Ste 2, Fitchburg, WI 53711 Phone: 608-628-0834 Fax: 608-442-5558 | |
Yelk Counseling, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2916 Marketplace Dr, Fitchburg, WI 53719 Phone: 608-733-1040 Fax: 608-467-7119 | |
Step Time, Inc. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2984 Triverton Pike Dr Ste 101, Fitchburg, WI 53711 Phone: 160-833-8354 | |
Blackstone Therapy, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2940 Chapel Valley Rd Ste 2, Fitchburg, WI 53711 Phone: 608-501-3600 Fax: 608-621-5162 | |
Abegglen Counseling & Consulting, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2976 Triverton Pike Dr Ste 110, Fitchburg, WI 53711 Phone: 608-445-6064 Fax: 608-298-3288 |